Svend K. Petersen-Mahrt
Medical Research Council
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Svend K. Petersen-Mahrt.
Nature | 2002
Svend K. Petersen-Mahrt; Reuben S. Harris; Michael S. Neuberger
After gene rearrangement, immunoglobulin variable genes are diversified by somatic hypermutation or gene conversion, whereas the constant region is altered by class-switch recombination. All three processes depend on activation-induced cytidine deaminase (AID), a B-cell-specific protein that has been proposed (because of sequence homology) to function by RNA editing. But indications that the three gene diversification processes might be initiated by a common type of DNA lesion, together with the proposal that there is a first phase of hypermutation that targets dC/dG, suggested to us that AID may function directly at dC/dG pairs. Here we show that expression of AID in Escherichia coli gives a mutator phenotype that yields nucleotide transitions at dC/dG in a context-dependent manner. Mutation triggered by AID is enhanced by a deficiency of uracil-DNA glycosylase, which indicates that AID functions by deaminating dC residues in DNA. We propose that diversification of functional immunoglobulin genes is triggered by AID-mediated deamination of dC residues in the immunoglobulin locus with the outcome—that is, hypermutation phases 1 and 2, gene conversion or switch recombination—dependent on the way in which the initiating dU/dG lesion is resolved.
Journal of Immunology | 2009
Siim Pauklin; Svend K. Petersen-Mahrt
Regulation of activation-induced deaminase (AID), an essential factor in Ig diversification, can alter not only somatic hypermutation and class switch recombination (CSR), but may also influence oncogenesis. AID deaminates cytosine to uracil in the Ig locus, thereby initiating Ig diversification. Unregulated AID can induce oncogenic DNA alterations in Ig and non-Ig loci, leading to mutations, recombination, and translocations. In this study, we demonstrate that AID mRNA production in activated mouse splenic B cells can be reduced by treatment with the sex hormone progesterone. This down-regulation is independent of translation or splicing and is predominantly achieved by inhibiting transcription. During cell treatment we could detect progesterone receptor bound to the AID promoter in proximity to NF-κB binding. Importantly, the progesterone-induced repression was also extended to the protein level of AID and its activity on somatic hypermutation and class switch recombination.
Autoimmunity | 2013
Elisabetta Incorvaia; Lara Sicouri; Svend K. Petersen-Mahrt; Kerstin-Maike Schmitz
The human immune system is a complex dynamic network of soluble factors and specialized cells that can and need to act in an instance or keep a lifelong protection, with the consequence that health has to be maintained through genetic and environmental stimuli. Autoimmunity is a multifactorial disease, where this combination of genetic predisposition and environmental factors lead to disease etiology. As some autoimmune diseases, such as systemic lupus erythematosus (SLE), rheumatoid arthritis (RA) or other B cell autoimmunities have a very strong female gender bias, hormones, especially estrogen, have been implicated as environmental factors in driving the disease. One of the key regulators of B cell development is activation-induced deaminase (AID), as its molecular mechanism of cytosine deamination induces immunoglobulin affinity maturation and antibody class switching. In this review we will highlight some of the recent findings of how estrogen directly and indirectly activates AID expression, which in turn can lead to immune hyper-stimulation. Those regulatory pathways can be direct when the estrogen receptor (ER) binds the AID promoter, or indirect via activation of transcription factors that enhance AID expression (e.g., HoxC4). Estrogens influence on AID will also be discussed in terms of microRNA processing for miRNA-155 and miRNA-181b. Important other external stimuli, such as EBV virus, in conjunction with estrogen can add another layer of regulation during autoimmune disease progression. Understanding these pathways will become more important as AID has now been implicated to play an important role in immune tolerance and actual elimination of autoantibodies.
Journal of Biological Chemistry | 2003
Svend K. Petersen-Mahrt; Michael S. Neuberger
Archive | 2010
Svend K. Petersen-Mahrt; Reuben S. Harris; Michael S. Neuberger; Rupert Christopher Landsdowne Beale
Archive | 2010
Katharina L. Willmann; Sven Kracker; Maria T. Simon; Don-Marc Franchini; Pauline Gardès; Anne Durandy; Svend K. Petersen-Mahrt
Journal of Immunology | 2015
Svend K. Petersen-Mahrt; Reuben S. Harris; Michael S. Neuberger
Journal of Cell Biology | 2012
Katharina L. Willmann; Sara Milosevic; Siim Pauklin; Kerstin-Maike Schmitz; Gopinath Rangam; Maria T. Simon; Sarah L. Maslen; Mark Skehel; Isabelle Robert; Vincent Heyer; Ebe Schiavo; Bernardo Reina-San-Martin; Svend K. Petersen-Mahrt
GBM Annual Spring meeting Mosbach 2008 | 2008
Svend K. Petersen-Mahrt; Wolf Reik; Siim Pauklin; Heather Coker
Cell | 2004
Reuben S. Harris; Kate N. Bishop; Ann M. Sheehy; Heather M. Craig; Svend K. Petersen-Mahrt; Ian N. Watt; Michael S. Neuberger; Michael H. Malim